3'-(3-methyl-2-butenyl)-4'-O-β-d-glucopyranosyl-4,2'-dihydroxychalcone for COVID-19

 3'-(3-methyl-2-butenyl)-4'-O-β-d-glucopyranosyl-4,2'-dihydroxychalcone has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed 3'-(3-methyl-2-butenyl)-4'-O-β-d-glucopyranosyl-4,2'-dihydroxychalcone in detail.
Khanal et al., Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105668